Abstract: Provided herein is a nanostructure refined by suspending an unrefined nanostructure with a solvent, dispersing the suspended nanostructure in an acidic solution and agitating the acidic solution to produce a refined nanostructure.
Type:
Application
Filed:
October 6, 2011
Publication date:
April 12, 2012
Applicant:
The Research Foundation of State University of New York
Inventors:
Stanislaus WONG, Christopher Koenigsmann
Abstract: The present invention relates to novel nucleic acid ligands or aptamers that demonstrate potent and selective inhibition of the open-channel conformation of the ?-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) subtype of ionotropic glutamate receptors.
Type:
Application
Filed:
October 8, 2010
Publication date:
April 12, 2012
Applicant:
The Research Foundation of State University of New York
Abstract: A method and a kit for the identification of chromosomal inversions are described. Chromosomal inversions are difficult to detect unless they are quite large. The improved ability to detect chromosomal inversions is important to a number of medical applications, such as cancer and birth defects, as examples. Reporter species are attached to oligonucleotide strands designed such that they may hybridize to portions of only one of a pair of single-stranded sister chromatids prepared by the CO-FISH procedure, as an example. If an inversion has occurred, these marker probes will be detected on the sister chromatid at the same location as the inversion on the first chromatid.
Type:
Application
Filed:
October 11, 2011
Publication date:
April 12, 2012
Applicants:
COLORADO STATE UNIVERSITY RESEARCH FOUNDATION, KROMATID, INC.
Abstract: Compounds and methods for treating cancer or inducing apoptosis in proliferating cells. The compounds are shown in formula I: wherein X is selected from hydroxyl, thiol, and amino; Y is selected from carboxyl and sulfonyl; R1, R2, R3, and R4 are selected from hydrogen, lower alkyl, and combinations thereof; R5, R6, and R7 are selected from hydrogen, halo, nitro, amino, methoxy, and combinations thereof; and pharmaceutically acceptable salts thereof.
Type:
Grant
Filed:
August 25, 2009
Date of Patent:
April 10, 2012
Assignee:
The Ohio State University Research Foundation
Abstract: Equol (7-hydroxy-3(4?hydroxyphenyl)-chroman), the major metabolite of the phytoestrogen daidzein, specifically binds and blocks the hormonal action of 5?-dihydrotestosterone (DHT) in vitro and in vivo. Equol can bind circulating free DHT and sequester it from the androgen receptor, thus altering growth and physiological hormone responses that are regulated by androgens. These data suggest a novel model to explain equol's biological properties. The significance of equol's ability to specifically bind and sequester DHT from the androgen receptor have important ramifications in health and disease and may indicate a broad and important usage for equol in the treatment and prevention of androgen-mediated pathologies. Thus, equol can specifically bind DHT and prevent DHT's biological actions in physiological and pathophysiological processes.
Type:
Grant
Filed:
October 2, 2009
Date of Patent:
April 10, 2012
Assignees:
Colorado State University Research Foundation, Brigham Young University Technology Transfer Office, Children's Hospital Medical Center of Cincinnati, Ohio
Inventors:
Edwin Douglas Lephart, Trent D. Lund, Kenneth David Reginald Setchell, Robert J. Handa
Abstract: Methods are provided for determining, in a single polymerase chain reaction (PCR) reaction, the quantity, quality, and gender of origin of DNA in a sample, and whether or not the sample contains PCR amplification inhibitors. The methods involve carrying out a single PCR multiplex reaction utilizing primer sets specific for amplifying the human amelogenin locus, an X- and/or Y-chromosome specific gene that is shorter than the amelogenin gene, and a heterologous, non-human reporter gene.
Type:
Grant
Filed:
December 19, 2007
Date of Patent:
April 10, 2012
Assignee:
The Board of Regents for Oklahoma State University
Abstract: Mutants of human FGF-1 are disclosed having increased stability and mitogenic potency. In the FGF-1 polypeptide, primarily residue 12 is substituted with threonine and/or residue 134 is substituted cysteine, valine or threonine to render the polypeptide more stable and/or to increase its mitogenecity.
Type:
Grant
Filed:
January 8, 2010
Date of Patent:
April 10, 2012
Assignee:
Florida State University Research Foundation, Inc.
Abstract: New RNA cap analogs are disclosed containing one or more phosphorothioates groups. The analogs also contain modifications at the 2?-O position of 7-methylguanosine that prevent them from being incorporated in the reverse orientation during in vitro synthesis of mRNA and that hence are “anti-reverse cap analogs” (ARCAs). The ARCA modification ensures that the S atom is precisely positioned within the active sites of cap-binding proteins in both the translational and decapping machinery. The new S-ARCA analogs are resistant to in vivo decapping enzymes. Some S-ARCAs have a higher affinity for eIF4E than the corresponding analogs not containing a phosphorothioate group. When mRNAs containing the various S-ARCAs are introduced into cultured cells, some are translated as much as five-fold more efficiently than mRNAs synthesized with the conventional analog m7GpppG.
Type:
Grant
Filed:
June 19, 2008
Date of Patent:
April 10, 2012
Assignees:
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, University of Warsaw
Inventors:
Jacek Jemielity, Ewa M. Grudzien-Nogalska, Joanna Kowalska, Edward Darzynkiewicz, Robert E. Rhoads
Abstract: Fluorophores derived from photoactivatable azide-pi-acceptor fluorogens or from a thermal reaction of an azide-pi-acceptor fluorogen with an alkene or alkyne are disclosed. Fluorophores derived from a thermal reaction of an alkyne-pi-acceptor fluorogen with an azide are also disclosed. The fluorophores can readily be activated by light and can be used to label a biomolecule and imaged on a single-molecule level in living cells.
Type:
Grant
Filed:
May 13, 2009
Date of Patent:
April 10, 2012
Assignees:
Kent State University, Leland Stanford Junior University
Inventors:
Robert J. Twieg, William E. Moerner, Samuel J. Lord, Na Liu, Reichel Samuel
Abstract: Herein disclosed are an electrode and a method for making an electrode having an enhanced electrically effective surface providing an increased signal to noise ratio. The electrode having a metal surface selected from gold, tungsten, stainless steel, platinum, platinum-tungsten, platinum-iridium, and combinations thereof; and an electrically conductive coating on said metal surface, said coating consisting essentially of polymerized pyrrole.
Type:
Grant
Filed:
July 12, 2010
Date of Patent:
April 10, 2012
Assignee:
Florida State University Research Foundation, Inc.
Abstract: The present invention provides a method of optical electrophysiological probing, including: providing a fluorescing chemical probe; contacting a thick portion of tissue with the fluorescing chemical probe to create a thick portion of treated tissue; applying a first range of wavelengths of electromagnetic radiation to the treated portion of tissue; and detecting a plurality of depth-specific emission wavelengths emitted from the thick portion of treated tissue.
Type:
Grant
Filed:
October 24, 2007
Date of Patent:
April 10, 2012
Assignee:
The Research Foundation of State University of New York
Inventors:
Arkady M. Pertsov, Arvydas Matiukas, Leslie M. Loew, Joseph P. Wuskell
Abstract: Mutants of human FGF-1 are disclosed having increased stability and mitogenic potency. In the FGF-1 polypeptide, primarily residue 12 is substituted with cysteine and/or residue 134 is substituted cysteine, valine or threonine to render the polypeptide more stable and/or to increase its mitogenecity.
Type:
Grant
Filed:
January 8, 2010
Date of Patent:
April 10, 2012
Assignee:
Florida State University Research Foundation, Inc.
Abstract: A hybrid CMOL stack enables more efficient design of CMOS logical circuits. The hybrid CMOL structure includes a first substrate having a CMOS device layer on the substrate, a first interconnect layer with interface pins over the CMOS device layer of the first substrate, a first array of nanowires connected to the interface pins of the first interconnect layer, a layer of nanowire junction material over the first array of nanowires, a second array of nanowires over the nanowire junction material, a second interconnect layer having interface pins disposed over the second array of nanowires, the interface pins being connected to the second array of nanowires, and a second substrate, the second substrate including a second CMOS device layer disposed over the second interconnect layer.
Type:
Grant
Filed:
March 27, 2008
Date of Patent:
April 10, 2012
Assignee:
The Research Foundation of State University of New York
Abstract: Nerve conduction studies (NCS) are used to diagnose many types of disorders and are being employed more and more frequently. Current methods for distance measurement during a NCS are manual and often time consuming and vulnerable to considerable error. A device and system for electronically measuring distance during a NCS and automatically transferring the data is disclosed. In one embodiment, the device incorporates a contact wheel to travel across the surface of the subject's skin to measure the applicable distance.
Abstract: One aspect of the present invention provides a method of treating or preventing angioedema in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R. One aspect of the present invention provides a method of treating or preventing vascular permeability in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R.
Type:
Application
Filed:
March 29, 2010
Publication date:
April 5, 2012
Applicant:
The Research Foundation of State University of New York
Abstract: The invention provides durable nonwoven fabrics comprising staple fibers. Methods of preparing durable nonwoven fabrics based on staple fibers are also provided. The methods can include the steps of at least one of needle punching and hydroentangling. The durable nonwoven fabric can be subjected to additional bonding techniques, such as resin bonding and/or thermal bonding. The durable nonwoven fabrics of the invention provide improved durability over conventional nonwoven fabrics. Further advantages of the inventive nonwoven fabrics include maintaining the smooth surface qualities of the fabric and desirable feel of the fabric even with the enhanced durability. The inventive nonwoven fabrics can also be subjected to additional post-processing techniques that conventional nonwoven fabrics would otherwise be unable to withstand. Further, inks and/or dyes can more readily become adhered to the smooth nature of the surfaces of the inventive durable nonwoven fabrics.
Abstract: Polyamine, polyamine/guanidino, and polyamine/biguanide compounds are disclosed. The compounds are useful as anti-cancer and anti-parasitic treatments. The compounds are also useful as inhibitors of the enzyme lysine-specific demethylase-1.
Type:
Grant
Filed:
April 20, 2010
Date of Patent:
April 3, 2012
Assignees:
The Johns Hopkins University, Wayne State University
Inventors:
Patrick M. Woster, Tracey Boncher, Robert A. Casero
Abstract: A eukaryotic input circuit: computationally designed receptors, synthetic eukaryotic signal transduction pathways, and a synthetic signal sensitive promoter that allow highly specific transcriptional induction in response to an externally provided ligand is disclosed. The input circuit is able to specifically bind a targeted substance and transmit a signal to the nucleus where transcription of a gene is activated. An output circuit serves as a simple readout system of the substance detected by the input circuit. The readout circuit exemplified here is a degreening circuit which causes plants to turn white. Activation of the degreening circuit can be detected by eye, or remotely with a variety of machines (hand-held, aircraft or satellite based) and is also resettable. When linked the input circuit if operably linked to the output circuit, produces a functional plant detector.
Type:
Grant
Filed:
April 25, 2007
Date of Patent:
April 3, 2012
Assignees:
Colorado State University Research Foundation, Duke University
Inventors:
June Medford, Mauricio S. Antunes, Kevin J. Morey, Homme W. Hellinga, James Jefferson Smith
Abstract: Biocompatible polyarylates of diphenol compounds and poly(alkylene oxide) dicarboxylic acids, articles formed therefrom and therapeutic uses are disclosed.
Type:
Grant
Filed:
May 5, 2010
Date of Patent:
April 3, 2012
Assignee:
Rutgers, The State University of New Jersey
Inventors:
Joachim B. Kohn, Satish Pulapura, Arthur Schwarz, Raman Bahulekar
Abstract: The present invention provides methods of protecting a surface of an aluminum nitride substrate. The substrate with the protected surface can be stored for a period of time and easily activated to be in a condition ready for thin film growth or other processing. In certain embodiments, the method of protecting the substrate surface comprises forming a passivating layer on at least a portion of the substrate surface by performing a wet etch, which can comprise the use of one or more organic compounds and one or more acids. The invention also provides aluminum nitride substrates having passivated surfaces.
Type:
Grant
Filed:
February 16, 2011
Date of Patent:
April 3, 2012
Assignee:
North Carolina State University
Inventors:
Ramon R. Collazo, Zlatko Sitar, Rafael Dalmau